Cardiology

New 'gene silencer' drug reduce cholesterol by over 50 percent

The findings come from the largest trial yet to test the safety and effectiveness of this kind of therapy. The technique, known as RNA interference (RNAi) therapy, essentially 'switches off' one of the genes responsible for ...

Medications

Evinacumab cuts LDL-C level in familial hypercholesterolemia

(HealthDay)—For patients with homozygous familial hypercholesterolemia, evinacumab lowers low-density lipoprotein (LDL) cholesterol levels, according to a study published in the Aug. 20 issue of the New England Journal ...

Cardiology

Migraine frequency, intensity linked to cholesterol levels

(HealthDay)—Migraine frequency and intensity seem to be positively associated with total cholesterol (TC) and low-density lipoprotein (LDL) cholesterol, according to a study published in the September issue of Pain Practice.

page 23 from 38